Atlas Trials

Effects of Yangxinshi Pills on the Exercise Tolerance Compared With Trimetazidine in Patients After PCI

Clinical trial NCT03809273 · COMPLETED

Trial details

NCT number
NCT03809273
Sponsor
Shenyang Northern Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Percutaneous Coronary Intervention
Start date
2019-08-01
Primary completion
2020-12-31
Enrollment
681

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.